Stock Track | Medtronic Plunges 5% Pre-Market on Lower Q3 Revenue and EPS Miss

Stock Track

Feb 18, 2025

Medtronic PLC (MDT), a leading medical device company, saw its stock plunge 5.18% in pre-market trading on Tuesday, following the release of its fiscal third-quarter 2025 earnings results.

The company reported revenue of $8.292 billion for the quarter ended January 24, 2025, slightly missing analyst estimates of $8.324 billion. The GAAP diluted earnings per share (EPS) came in at $1.01, lower than the expected $1.07. Although Medtronic reported non-GAAP diluted EPS of $1.39, beating estimates of $1.36, the overall results fell short of market expectations.

According to the earnings report, Medtronic faced challenges in its Medical Surgical Portfolio, which saw a 1.9% revenue decline attributed to pressures in the stapling segment and changes in distributor buying patterns. However, the company's Cardiovascular, Neuroscience, and Diabetes portfolios showed growth, with the Diabetes segment reporting an impressive 8.4% revenue increase driven by the adoption of the MiniMed™ 780G system.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1123404802"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123404802\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123404802?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-18 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123404802","market":"us","top_or_hot":-1,"title":"Stock Track | Medtronic Plunges 5% Pre-Market on Lower Q3 Revenue and EPS Miss","media":"Stock Track","content":"<p>Medtronic PLC (MDT), a leading medical device company, saw its stock plunge 5.18% in pre-market trading on Tuesday, following the release of its fiscal third-quarter 2025 earnings results.</p>\n\n<p>The company reported revenue of $8.292 billion for the quarter ended January 24, 2025, slightly missing analyst estimates of $8.324 billion. The GAAP diluted earnings per share (EPS) came in at $1.01, lower than the expected $1.07. Although Medtronic reported non-GAAP diluted EPS of $1.39, beating estimates of $1.36, the overall results fell short of market expectations.</p>\n\n<p>According to the earnings report, Medtronic faced challenges in its Medical Surgical Portfolio, which saw a 1.9% revenue decline attributed to pressures in the stapling segment and changes in distributor buying patterns. However, the company's Cardiovascular, Neuroscience, and Diabetes portfolios showed growth, with the Diabetes segment reporting an impressive 8.4% revenue increase driven by the adoption of the MiniMed™ 780G system.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Medtronic Plunges 5% Pre-Market on Lower Q3 Revenue and EPS Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Medtronic Plunges 5% Pre-Market on Lower Q3 Revenue and EPS Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-18 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medtronic PLC (MDT), a leading medical device company, saw its stock plunge 5.18% in pre-market trading on Tuesday, following the release of its fiscal third-quarter 2025 earnings results.</p>\n\n<p>The company reported revenue of $8.292 billion for the quarter ended January 24, 2025, slightly missing analyst estimates of $8.324 billion. The GAAP diluted earnings per share (EPS) came in at $1.01, lower than the expected $1.07. Although Medtronic reported non-GAAP diluted EPS of $1.39, beating estimates of $1.36, the overall results fell short of market expectations.</p>\n\n<p>According to the earnings report, Medtronic faced challenges in its Medical Surgical Portfolio, which saw a 1.9% revenue decline attributed to pressures in the stapling segment and changes in distributor buying patterns. However, the company's Cardiovascular, Neuroscience, and Diabetes portfolios showed growth, with the Diabetes segment reporting an impressive 8.4% revenue increase driven by the adoption of the MiniMed™ 780G system.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDT","symbol_name":"美敦力","start_time":0,"source_url":"","article_id":"1123404802","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123404802","pubTimestamp":1739885080,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Medtronic PLC , a leading medical device company, saw its stock plunge 5.18% in pre-market trading on Tuesday, following the release of its fiscal third-quarter 2025 earnings results.The company reported revenue of $8.292 billion for the quarter ended January 24, 2025, slightly missing analyst estimates of $8.324 billion. The GAAP diluted earnings per share  came in at $1.01, lower than the expected $1.07. Although Medtronic reported non-GAAP diluted EPS of $1.39, beating estimates of $1.36, the","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDT":"美敦力"},"translate_title":"美敦力(Medtronic)因第三季度收入下降和每股收益未达预期而盘前暴跌5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1},"content_text":"Medtronic PLC (MDT), a leading medical device company, saw its stock plunge 5.18% in pre-market trading on Tuesday, following the release of its fiscal third-quarter 2025 earnings results.\nThe company reported revenue of $8.292 billion for the quarter ended January 24, 2025, slightly missing analyst estimates of $8.324 billion. The GAAP diluted earnings per share (EPS) came in at $1.01, lower than the expected $1.07. Although Medtronic reported non-GAAP diluted EPS of $1.39, beating estimates of $1.36, the overall results fell short of market expectations.\nAccording to the earnings report, Medtronic faced challenges in its Medical Surgical Portfolio, which saw a 1.9% revenue decline attributed to pressures in the stapling segment and changes in distributor buying patterns. However, the company's Cardiovascular, Neuroscience, and Diabetes portfolios showed growth, with the Diabetes segment reporting an impressive 8.4% revenue increase driven by the adoption of the MiniMed™ 780G system.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}